• Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$1.59
▲ +0.17 (11.97%)

This chart shows the closing price for YI by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New 111 Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for YI and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for YI

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for 111 in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a -100.00% upside from the last price of $1.59.

This chart shows the closing price for YI for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in 111. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/2/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/2/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/31/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/29/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/27/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/25/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/26/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/26/2022

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/8/2018JPMorgan Chase & Co.Initiated CoverageOverweight ➝ OverweightHigh
(Data available from 5/26/2017 forward)

News Sentiment Rating

0.25 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 2 very positive mentions
  • 9 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
10/28/2021
  • 0 very positive mentions
  • 13 positive mentions
  • 2 negative mentions
  • 2 very negative mentions
11/27/2021
  • 2 very positive mentions
  • 8 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
12/27/2021
  • 1 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/26/2022
  • 2 very positive mentions
  • 8 positive mentions
  • 3 negative mentions
  • 2 very negative mentions
2/25/2022
  • 0 very positive mentions
  • 16 positive mentions
  • 0 negative mentions
  • 2 very negative mentions
3/27/2022
  • 2 very positive mentions
  • 12 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
4/26/2022
  • 3 very positive mentions
  • 6 positive mentions
  • 4 negative mentions
  • 1 very negative mentions
5/26/2022

Current Sentiment

  • 3 very positive mentions
  • 6 positive mentions
  • 4 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

111 logo
111, Inc. operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2B and B2C. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services, such as online consultation services and e-prescription services to consumers. Its product portfolio comprises prescription and over-the counter drugs, such as western and traditional Chinese medicinal drugs; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices, including bandages and thermometers; and personal care products, such as skin care, birth control, and sexual wellness products; and baby products. The company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 Drug Mall, including pharmacies and wholesalers; and digital contract sales organization and data services. As of December 31, 2020, it operated 13 offline retail pharmacies under the Yi Hao Pharmacy brand name in Guangzhou, Wuhan, Tianjin, and Kunshan. In addition, the company offers warehousing, logistics, procurement, research and development, and consulting services; and software development and information technology support services. It serves pharmacies, pharmaceutical companies and distributors, medical professionals, and insurance companies. 111, Inc. has strategic partnerships with Bayer Healthcare Co. Ltd.; BeiGene, Ltd.; Jianming Pharmaceutical Group; and Chugai Pharma China Co., Ltd. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.
Read More

Today's Range

Now: $1.59
Low: $1.46
High: $1.59

50 Day Range

MA: $2.24
Low: $1.42
High: $3.23

52 Week Range

Now: $1.59
Low: $1.37
High: $10.64

Volume

36,846 shs

Average Volume

567,013 shs

Market Capitalization

$131.46 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.91

Frequently Asked Questions

What sell-side analysts currently cover shares of 111?

The following Wall Street research analysts have issued reports on 111 in the last twelve months:
View the latest analyst ratings for YI.

What is the current price target for 111?

0 Wall Street analysts have set twelve-month price targets for 111 in the last year.
View the latest price targets for YI.

What is the current consensus analyst rating for 111?

111 currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for YI.

How do I contact 111's investor relations team?

111's physical mailing address is 3-5/F NO.295 ZUCHONGZHI ROAD PUDONG NEW AREA, SHANGHAI F4, 201203. The company's listed phone number is 862120536666. The official website for 111 is www.111.com.cn. Learn More about contacing 111 investor relations.